Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
Background: Cancer immunotherapy is rapidly expanding but its clinical efficacy is hampered by immune related adverse events (ir-AE). There is a concern regarding patients with pre-existing auto-immune diseases (PAD) undergoing immunotherapy. Methods: An electronic search was performed (Medline) to...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
PCO Convin S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5901a31e50854285a3a7d0f1078a6873 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|